Premature Luteinization Prevention by GnRH Antagonist in Patients Undergoing IUI

• Status: Completed
• Trial end date: 2011-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

Premature luteinization in patients undergoing IUI can occur in up to 24% of cycles. These patients, according to recent data, have a lower pregnancy rate than controls. The possibility to avoid premature luteinization with GnRH antagonist may restore the chances of achieving a pregnancy in these women.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: IVI Madrid
• Treatments: Ganirelix

Criteria

Inclusion Criteria:

• previous failed IUI cycle with premature luteinization

Exclusion Criteria:

• 39 years or older

• not eligible for IUI (patent tubes, > 3 million capacitated spermatozoa)

• 4 previous IUI cycles